Within this project, we aimed to use a semi to high-throughput approach to evaluate various protein-fat matrix formulations (including processing conditions) and screen a selection of microorganisms and their impact on texture and taste formation (during ageing).
Whether you are introducing a new technology, gathering feedback on a process, or looking to strengthen your network, our event services offer the ideal setting to connect with the UK’s advanced therapy community.
LifeArc's newly launched B-SMArT antibody discovery platform offers collaborators a clinically validated transgenic mouse model (Kymab/Sanofi) and advanced single B-cell selection technologies (Beacon and FACS) to generate fully human antibodies ready for in vivo testing.
